{name}
{subtitle}
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
city
~13 mi. (Oak Ridge, Tennessee, +413 more cities)
facility
Thompson Oncology Group-Oak Ridge
drug
ipilimumab, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~21 mi. (Knoxville, Tennessee, +144 more cities)
facility
University of Tennessee Medical Center Knoxville ( Site 0019)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~21 mi. (Knoxville, Tennessee, +89 more cities)
facility
University of Tennessee Medical Center ( Site 0039)
biomarker
ER Positive, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~21 mi. (Knoxville, Tennessee, +454 more cities)
facility
East Tennessee Childrens Hospital
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~21 mi. (Knoxville, Tennessee, +93 more cities)
facility
The University of Tennessee Medical Center ( Site 0034)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
city
~21 mi. (Knoxville, Tennessee, +199 more cities)
facility
Research Site
drug
bevacizumab, +2 more drugs
drug type
immunotherapy, +1 more type
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~21 mi. (Knoxville, Tennessee, +122 more cities)
facility
The University of Tennessee Medical Center ( Site 0116)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types